Comparative Benchmarking for Hypertension

Knowing where you stand in quality outcomes should be an essential part of your overall medical group or health system strategy. AMGA is pleased to announce a new member benefit: blinded, comparative benchmarking reports for hypertension control.

We believe this complimentary offering is particularly valuable and timely as organizations prepare for upcoming payment changes in the Medicare Access & CHIP Reauthorization Act of 2015 (MACRA). Our reports will integrate Merit-Based Incentive Payment System (MIPS) target benchmarks for hypertension control, so you can see how your performance will impact MACRA reimbursement beginning in 2017. Because scores are relative to your peers, it is critical to understand your comparative performance as you determine which quality measures to report on and the expected reimbursement.

This benefit is also a natural extension of AMGA Foundation’s first national health campaign, Measure Up/Pressure Down®. During this quality improvement effort focused on hypertension, over 90 organizations were included in these reports, allowing groups to benchmark their performance, celebrate their successes, disseminate best practices across the organization, and receive recognition for their organization’s performance.

Please note that this hypertension data reporting will be contingent on overall participation rates.

How to Submit Hypertension Control Data

  • Download hypertension reporting Excel template here

  • Run a report of your hypertensive patients (specifications can follow NQF 0018 annual, NQF 0018 quarterly, or Measure Up/Pressure Down® specifications)

  • Manually enter your hypertension control data into the tab corresponding to the chosen specifications on the Excel template manually (please be sure to include your organization’s name in the space provided at the top of the worksheet)

  • Submit the Excel template by attaching it to an email and sending it to  by September 30, 2016

  • Leverage the blinded, comparative data reports sent in late October to advance your hypertension control efforts and to determine which quality measures to report on and the expected reimbursement for MACRA

Questions? Please email